• Skip to main content

DistilINFO LifeSciences

Weekly round up from Life Sciences Industry.

  • Publications
    • Home
    • DistilINFO HealthPlan
    • DistilINFO HospitalIT
    • DistilINFO IT
    • DistilINFO Retail
    • DistilINFO POPHealth
    • DistilINFO Ageing
    • DistilINFO Life Sciences
    • DistilINFO GovHealth
    • DistilINFO EHS
    • DistilINFO HealthIndia
    • Subscribe
    • Submit Article
    • Advertise
    • Newsletters

Cantel Expands its Life Sciences Portfolio through Acquisition of Stericycle’s Controlled Environmental Solutions Business

Share:

August 13, 2018

Addition of clean room business enhances and strengthens Cantel’s portfolio of infection prevention solutions

Cantel Medical Corp., announced today that it has acquired Stericycle, Inc.’s Controlled Environmental Solutions business for a cash purchase price of $17.0 million on a cash-free and debt-free basis. The CES business, consisting of B&V Testing and Certco services, is a leading provider of testing and certification, environmental monitoring and decontamination services for clean rooms and other controlled environments to ensure safety, regulatory compliance and quality control.

For the calendar year ending December 31, 2017, the CES business reported revenues of $8.9 million. Cantel anticipates the acquisition to be accretive to non-GAAP earnings per share in the fiscal year ending July 31, 2019 and beyond, and accretive to GAAP earnings per share in the fiscal year ending July 31, 2020 and beyond.

The CES business is made up of highly specialized testing and certification services, control procedures and tailored decontamination technology for the clean room to ensure optimal performance of the environment and end-user compliance to highly regulated industry standards.

Want to publish your own articles on DistilINFO Publications?

Send us an email, we will get in touch with you.

“We are pleased that the CES business is now part of Cantel and welcome their employees to our team. Their services are highly complementary to our current portfolio of sterilization and disinfection products, and enable us to expand the complete circle of protection product offerings in our Life Sciences portfolio,” stated Jorgen Hansen, President and CEO. “We’re excited about the attractive emerging market of clean room testing, certification and decontamination and are optimistic that this platform will position us well for meaningful growth in the future.”

“This acquisition allows us to better serve customers in the clean room products and services market,” said Curt Weitnauer, President of Cantel’s Water Purification and Filtration Division. “By joining forces, we will enhance the value we provide to existing and future customers by coupling the CES Business’ strong reputation for technical and service excellence with our expertise to deliver high-quality, and innovative infection prevention solutions.”

Date: August 13, 2018

Source: CISION

Coffee with DistilINFO's Morning Updates...

Sign up for DistilINFO e-Newsletters.

Just a little bit more about you...
PROCEED
Choose Lists
BACK

Related Stories

  • Canon Medical Launches New Premium MR System: Vantage Orian 1.5TCanon Medical Launches New Premium MR System: Vantage Orian 1.5T
  • Advaxis and Biosight Announce Entry Into Definitive Merger AgreementAdvaxis and Biosight Announce Entry Into Definitive Merger Agreement
  • Reify Health Raises $30M to Fix The Broken Clinical Trial EcosystemReify Health Raises $30M to Fix The Broken Clinical Trial Ecosystem
  • AdhereHealth Launches COVID-19 Adherence Solution for High Risk PopulationsAdhereHealth Launches COVID-19 Adherence Solution for High Risk Populations
  • Civica Rx Partners with Thermo Fisher Scientific to Develop and Manufacture Drugs with a History of Drug ShortagesCivica Rx Partners with Thermo Fisher Scientific to Develop and Manufacture Drugs with a History of Drug Shortages
  • Nicoya Raises $10 Million in Series A Funding to Make Drug Discovery DigitalNicoya Raises $10 Million in Series A Funding to Make Drug Discovery Digital
  • European and U.s. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses By SartoriusEuropean and U.s. Antitrust Authorities Clear Acquisition of Select Danaher Life Science Businesses By Sartorius
  • Lodo Therapeutics Acquires Conifer Point PharmaceuticalsLodo Therapeutics Acquires Conifer Point Pharmaceuticals

Trending This Week

Sorry. No data so far.

About Us

DistilINFO is media company that publishes Industry news, views and Interviews. We distil the information for you – saving time and keeping you up to date on your interest areas.

More About Us

Follow Us


Useful Links

  • Subscribe
  • Contact
  • Advertise
  • Privacy Policy
  • Terms of Service
  • Feedback

All Publications

  • DistilINFO HealthPlan Advisory
  • DistilINFO HospitalIT Advisory
  • DistilINFO IT Advisory
  • DistilINFO Retail Advisory
  • DistilINFO POPHealth Advisory
  • DistilINFO Ageing Advisory
  • DistilINFO Life Sciences Advisory
  • DistilINFO GovHealth Advisory
  • DistilINFO EHS Advisory
  • DistilINFO HealthIndia Advisory

© DistilINFO Publications